Cargando…

390. Corticosteroid Treatment in Severe Patients with SARS-CoV-2 and Chronic HBV Co-infection: A Retrospective Multicenter Study

BACKGROUND: The impact of corticosteroids on patients with severe coronavirus disease 2019 (COVID-19)/chronic hepatitis B virus (HBV) co-infection is currently unknown. We aimed to investigate the association of corticosteroids with these patients. METHODS: This retrospective multicenter study scree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biju, Sanju, Paulson, Shon, Raju, Jomel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678988/ http://dx.doi.org/10.1093/ofid/ofad500.460

Ejemplares similares

429. Risk of COVID-19 Related Deaths for SARS-CoV-2 Omicron (B.1.1.529) Compared With Delta (B.1.617.2): A Retrospective Cohort Study
por: Paulson, Shon, et al.
Publicado: (2023)

Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study
por: Meng, Mei, et al.
Publicado: (2022)

390. Can Testing the Environment for SARS-CoV-2 Be a Signal for Staff Infections in Nursing Homes (NHs)?
por: Gussin, Gabrielle, et al.
Publicado: (2021)

260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients
por: Swets, Maaike C, et al.
Publicado: (2022)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection
por: Morrison, Austin R, et al.
Publicado: (2022)

542. Evaluation of Remdesivir to the Outcomes of Hospitalized Patients with COVID-19 Infection in a Tertiary Care Hospital in Southern India
por: Raju, Jomel, et al.
Publicado: (2023)

390 Protamine Allergy
por: Hafner, Christine, et al.
Publicado: (2012)

1783. Acute Kidney Injury Associations with Antibiotics: A Pharmacovigilance Study of the US FDA Adverse Event Reporting System
por: Kochuparambil, Jose J, et al.
Publicado: (2023)

1846. Quality of Life Impairment and Difficulty to Work Associated with Post-COVID Syndrome: A Cross-Sectional Study
por: Kochuparambil, Jose J, et al.
Publicado: (2023)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

Corticosteroid Therapy in Severe Cases of Pneumonia Caused by SARS-CoV-2
por: Alves, João, et al.
Publicado: (2022)

Modeling SARS-CoV-2 and HBV co-dynamics with optimal control
por: Omame, Andrew, et al.
Publicado: (2023)

296. SARS-CoV-2 Illness Severity and Early Hospitalization Outcomes in a Multicenter Prospective Cohort Study Among Veterans
por: Ross, Jennifer M, et al.
Publicado: (2022)

The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial
por: Ghanei, Mostafa, et al.
Publicado: (2021)

436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults
por: Priyadarshi, Megha, et al.
Publicado: (2023)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

Ventilatory support and corticosteroid therapy in SARS-CoV-2
por: Sagasti, Fernando Martínez, et al.
Publicado: (2021)

Safe administration of corticosteroids in severe ulcerative colitis and active SARS-CoV2 infection
por: Mayer, Pierre, et al.
Publicado: (2020)

Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
por: Lee, Kyung-Yil, et al.
Publicado: (2020)

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020)

MED19/390: Developing a Digital Textbook on Biomedical Technology for Health-Care Professionals
por: Spyropoulos, B
Publicado: (1999)

390. Treatment and Outcome of Methicillin-Resistant Staphylococcus aureus Hip and Knee Prosthetic Joint Infection
por: Henry, Michael, et al.
Publicado: (2019)

482. Long-Term Outcomes of Coronavirus disease 2019 and Risk Factors for Prolonged SARS-CoV-2 Infection in Lymphoma Patients: Multicenter, Retrospective Cohort Study
por: Lee, Jung Ah, et al.
Publicado: (2023)

373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2020)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

In-hospital mortality in SARS-CoV-2 stratified by the use of corticosteroid
por: Alotaibi, Naser, et al.
Publicado: (2022)

390 Evaluating Guideline-Recommended Antibiotic Prescribing Practices: Azithromycin for what?
por: Wright, Heather, et al.
Publicado: (2014)

295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series.
por: Trigueros, Ricardo, et al.
Publicado: (2022)

SARS-CoV2 vaccination status among psychiatry inpatients: a retrospective cohort analysis
por: Andreu, H., et al.
Publicado: (2023)

Neuropsychiatric manifestations of SARS-CoV-2 infection
por: Nogueira, V., et al.
Publicado: (2021)

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
por: Li, Huan, et al.
Publicado: (2020)

464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023)

452. Ongoing Surveillance of SARS-CoV-2 for In Silico Analysis to Monitor the Performance of SARS-CoV-2 Assays in BIOFIRE® Panels
por: Horrocks, Eleanor K, et al.
Publicado: (2023)

PM390. Comparison of Fast Versus Slow Strategy in Switching Schizophrenia Patients to Aripiprazole from Other Antipsychotics
por: Hwang, Tzung-Jeng, et al.
Publicado: (2016)

390. Sociodemographic Factors Associated With Patients Hospitalized for Coccidioidomycosis in California and Arizona, State Inpatient Database 2005–2011
por: Kupferwasser, Deborah, et al.
Publicado: (2018)

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection
por: Zou, Xiaojing, et al.
Publicado: (2021)

1356. "Correlates of protection against SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study"
por: Goguet, Emilie, et al.
Publicado: (2023)

1336. Presence of Antibodies to non-SARS-CoV-2 Associates With Generation of Neutralizing Antibodies to SARS-CoV-2 Following mRNA Vaccination
por: Al Hammoud, Roukaya, et al.
Publicado: (2023)

ABCs of OS/390 system programming..
por: Rogers, Paul
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_mc3h3noqk5ceme14saai0akvt7